The active compounds (carvacrol, thymol) have been shown to kill pathogens in both lab and some clinical settings.
Reviewed March 2026
Source: Force et al. 2000 Phytother Res; Singletary 2010 Nutr Today review.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Oregano has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Carvacrol and thymol from oregano disrupt microbial membranes without distinguishing lactobacilli from other organisms, so taking both in the same dose works against the live cultures. Common practice is to separate them by several hours.
The active phenolics in oregano are lipophilic volatile oils that dissolve in medium-chain triglycerides rather than in water. A carrier oil disperses them evenly and dilutes a concentrate that would otherwise irritate mucous membranes.
Thyme and oregano both yield thymol and carvacrol, isomeric monoterpene phenols that act on microbial membranes by the same route. Pairing them shifts the ratio of the two isomers rather than adding a separate mechanism.
Thyme is dominated by thymol and oregano by carvacrol, two isomeric phenolic monoterpenes that both alter microbial membrane permeability. Combining them puts both isomers in one blend.
The phenolic compounds in oregano leaf bind non-heme iron in the gut lumen and form complexes the intestine takes up poorly. Separating an iron dose from a polyphenol-rich herb by a couple of hours avoids that competition.
Carvacrol-rich oregano oil is lipophilic and does not disperse in an aqueous gut lumen on its own. Lecithin emulsifies it into fine droplets, which spreads the same dose over more surface and cuts the concentrated contact that makes undiluted phenolic oil harsh on mucosa. This is a delivery relationship, not an added effect of its own.
Steam-distilled oregano oil carries monoterpenes that oxidise on exposure to air, light and warmth, which shifts the aroma and the phenolic profile of the bottle over time. Tocopherols are added as an oil-phase antioxidant to slow that drift. The benefit is to the product's stability, and it says nothing about what either ingredient does in the body.
Rosemary extract is a standard oil-soluble antioxidant in botanical oil blends and is often paired with oregano for that reason. The two plants sit in the same family and share phenolic diterpene and phenolic acid classes, so a blend broadens the phenolic profile rather than concentrating one molecule. Whether the combination does more in a person than either alone has not been measured.
Both carvacrol and caprylic acid are small lipophilic molecules that partition into microbial lipid membranes and raise their permeability. Blends built for gut microbial balance commonly stack them because the mechanism overlaps rather than duplicating a single target. The overlap is characterised in laboratory culture; it is not an outcome measured in people.
Garlic's organosulfur compounds and oregano's phenolic monoterpenes both act on microbial membranes and thiol chemistry, and the pair turns up together in traditional culinary and botanical practice. In laboratory culture the two classes act by different chemistry on a similar target, which is the usual argument for combining them. Human data on the combination is not available.
Berberine is a water-soluble alkaloid and carvacrol is a lipophilic phenol, so the two reach different compartments of the gut lumen and act by different chemistry while supporting the same normal microbial balance. That non-overlap is the reason formulators pair them. Neither the additivity nor the dose ratio has been tested together in people.
Ginger and oregano appear together in culinary and traditional digestive preparations, and both are pungent botanicals associated with gastric secretion and motility. The pairing is long-standing rather than trial-tested. Read it as customary practice with a plausible mechanism, not as a measured combination effect.
Peppermint oil and oregano oil are both volatile, both irritating to the oesophagus undiluted, and both are usually delivered in an enteric or emulsified capsule for the same reason. Blending them lets one delayed-release shell carry two oils past the stomach. The shared delivery need is established; a combined effect in people is not documented.
Carvacrol and thymol permeabilise bacterial membranes broadly in culture, and lactic acid bacteria are bacteria, so a concentrated oil dose taken at the same moment as live cultures can reduce the viable count that arrives downstream. Practitioners separate the two doses by several hours for that reason. The competition is a laboratory finding about viability, not a measured loss of any clinical benefit.
Activated charcoal binds small lipophilic organic molecules with high capacity, and carvacrol is exactly that kind of molecule. Taken together, the charcoal lowers how much free oregano phenol is available in the lumen. Separate the two if both are on a regimen.
Bentonite adsorbs organic molecules onto its layered mineral surface, and a volatile phenol taken in the same window can be carried through bound rather than free. The direction of the interaction is predictable from the mineral's chemistry. How much of an oregano dose is lost has not been quantified in people.
Piperine inhibits several CYP isoforms and P-glycoprotein, which is why it raises exposure to some co-dosed compounds. Carvacrol and thymol are cleared mainly by glucuronidation and sulfation, so a change in exposure is possible but not characterised. Flagged as a plausible modulation to watch rather than an enhancement to count on.
Both oregano's phenols and silymarin flavonolignans are handled largely by glucuronidation and sulfation in the liver and gut wall. Heavy simultaneous loads on the same conjugation capacity can shift the clearance of either one. The pathway overlap is established; the size of any real shift at supplement doses is unknown.
Saccharomyces boulardii is a yeast, so the antibacterial reach of carvacrol does not apply to it in the way it applies to lactic acid bacteria. That is why it is sometimes chosen as the microbial partner during a botanical course. The reasoning is mechanical rather than trial-based, and phenolic oils do have antifungal activity in culture, so the pairing is not free of tension.
Talk to a doctor before taking Oregano if any of these apply to you: Oil form can irritate GI tract, May interact with blood thinners, Not for long-term high-dose use. These are flags to check first, not effects Oregano is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 3,358 we read for Oregano. The full linked list is below.
5 sources behind our Oregano verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 2,422 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Oregano is, not how risky it is. A report is not proof Oregano caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.